151 related articles for article (PubMed ID: 8865916)
1. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
2. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
[TBL] [Abstract][Full Text] [Related]
3. Gemfibrozil in CAPD patients.
De Vecchi A; Scalamogna A; Pini C; Castelnovo C; Colombini M; Lepore R
Adv Perit Dial; 1991; 7():240-2. PubMed ID: 1680435
[TBL] [Abstract][Full Text] [Related]
4. Effect of simvastatin in CAPD patients with hypercholesterolemia.
De Vecchi A; Scalamogna A; Paparella M; Colombini M; Rovellini A; Pini C; Castelnovo C
Adv Perit Dial; 1992; 8():331-3. PubMed ID: 1361817
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J
Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias].
Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M
Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of the lipid-lowering effect of simvastatin and tiadenol].
Serra T; Gavelli MS; Vitaliano E; Santini G; Catalano A; Rossi FG; Tozzi J; Caridis R; Guarini G
Clin Ter; 1990 Mar; 132(5):307-13. PubMed ID: 2139833
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants.
Farmer JA; Washington LC; Jones PH; Shapiro DR; Gotto AM; Mantell G
Clin Ther; 1992; 14(5):708-17. PubMed ID: 1468089
[TBL] [Abstract][Full Text] [Related]
9. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
10. [Mid-term clinical study of the effectiveness of and tolerability to simvastatin ++ in dyslipidemic patients].
Irace L; Aiello C; Papa A; Sannino A; Petraglia L; De Lucia R; Dragonetti C
Minerva Med; 1992 Dec; 83(12):815-8. PubMed ID: 1491761
[TBL] [Abstract][Full Text] [Related]
11. [Effects of simvastatin on atherogenic blood lipid pattern].
Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
[TBL] [Abstract][Full Text] [Related]
12. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J
Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G
Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A
Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.
Ros E; Zambón D; Bertomeu A; Cusó E; Sanllehy C; Casals E
Arch Intern Med; 1991 Feb; 151(2):301-5. PubMed ID: 1992957
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the therapeutic efficacy of pravastatin in monothereapy and in association with gemfibrozil in hypercholesterolemia associated with moderate hyperglyceridemia].
Napoli C; Lepore S; Ambrosio G; Chiariello M
Cardiologia; 1992 Nov; 37(11):761-8. PubMed ID: 1298545
[TBL] [Abstract][Full Text] [Related]
17. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
McKenney JM; Barnett MD; Wright JT; Proctor JP
Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045
[TBL] [Abstract][Full Text] [Related]
18. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH
Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
Behrens-Baumann W; Thiery J; Wieland E; Fieseler HG; Seidel D
Arzneimittelforschung; 1992 Aug; 42(8):1023-4. PubMed ID: 1418074
[TBL] [Abstract][Full Text] [Related]
20. [Dyslipidemia in the uremic patient: the therapeutic role played by simvastatin].
Bellinghieri G; Angelé B; Savica V
Clin Ter; 1992 Jan; 140(1 Pt 2):11-6. PubMed ID: 1559316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
